Trial Profile
A phase II trial of OSE-1101 for the treatment of cystic fibrosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2016
Price :
$35
*
At a glance
- Drugs Tritoqualine (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 06 Feb 2016 New trial record